WASHINGTON INSTITUTE FOR COAGULATION

EIN: 832302258 501(c)(3) Diseases & Disorders

SEATTLE, WA

Total Revenue
$112,675,357
Total Expenses
$101,694,334
Total Assets
$87,751,207
Net Assets
$65,010,128
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2018
Legal Domicile
WA
Principal Officer
EVA SZYSZKA
Phone
2066141200
Tax Period
2024-07-01 to 2025-06-30

WASHINGTON INSTITUTE FOR COAGULATION, founded in 2018, is a major nonprofit in the Diseases & Disorders sector that reported $112.7M in total revenue in fiscal year 2024. Revenue decreased 8% compared to the prior year. Expenses of $101.7M left a modest 10% surplus.

Mission

THE WASHINGTON CENTER FOR BLEEDING DISORDERS IS DEDICATED TO ASSURING OPTIMAL HEALTH FOR PEOPLE WITH BLEEDING DISORDERS THROUGH COMPREHENSIVE CARE, EDUCATION, AND RESEARCH.

Program Service Accomplishments

Program 1
Expenses: $8,408,236 Revenue: $397,679

CLINICAL SERVICES: AS A RECOGNIZED HEMOPHILIA TREATMENT CENTER AND ACENTER OF EXCELLENCE, WE ARE COMMITTED TO THE WELLBEING OF PATIENTSWITH AN INHERITED BLEEDING DISORDER ACROSS THE STATE OF...

Read more

CLINICAL SERVICES: AS A RECOGNIZED HEMOPHILIA TREATMENT CENTER AND ACENTER OF EXCELLENCE, WE ARE COMMITTED TO THE WELLBEING OF PATIENTSWITH AN INHERITED BLEEDING DISORDER ACROSS THE STATE OF WASHINGTON,NEIGHBORING STATES, AND ALASKA. WE ARE DEDICATED TO REFINED DIAGNOSISAND ASSESSMENT, SECURE ACCESS TO THERAPIES AND COMPREHENSIVETREATMENT PLANNING AND READILY AVAILABLE CONSULTATION. WE STRIVE TOFOSTER OUR PATIENTS' AUTONOMY TO SAFELY CARE FOR THEIR DISORDER ANDCAUSE MINIMAL DISRUPTION TO THEIR LIVES. A MULTIDISCIPLINARY TEAM OFHEALTH-CARE PROFESSIONALS ADDRESSES CONCERNS INCLUDING DIAGNOSIS,TREATMENT, EDUCATION, HEALTH INSURANCE, ORTHOPEDICS, AND DENTISTRY.EXPERT PEDIATRIC SERVICES ARE COORDINATED WITH SPECIALISTS AT SEATTLECHILDREN'S HOSPITAL IN SEATTLE, PROVIDENCE SACRED HEART MEDICAL CENTERAND CHILDREN'S HOSPITAL IN SPOKANE, AND MARY BRIDGE MEDICAL CENTERAND CHILDREN'S HOSPITAL IN TACOMA. OUTREACH CLINICS ARE CONDUCTED INTRI-CITIES, YAKIMA, SPOKANE, WENATCHEE, OLYMPIA, AND SEDRO-WOOLLEY.HOME VISITS TO FAMILIES AND IN-SERVICE MEETINGS WITH HEALTH-CAREPROFESSIONALS ARE PROVIDED THROUGHOUT THE STATE OF WASHINGTON.PROGRAM STAFF ALSO COORDINATE COMMUNITY RESOURCES FOR HEMOPHILIACARE, EMERGENCY ROOM TREATMENT, INVASIVE PROCEDURES, AND OTHERMEDICAL SPECIALTY CLINICS.

Program 2
Expenses: $90,777,125 Revenue: $110,397,664

PHARMACY SERVICES: AS AN INTEGRAL PART OF OUR COMPREHENSIVE CAREMODEL, OUR PHARMACY PROVIDES BLOOD CLOTTING FACTOR PRODUCTS TOPATIENTS AND HOSPITAL PROVIDERS THROUGHOUT THE STATE OF WASHINGTONAND...

Read more

PHARMACY SERVICES: AS AN INTEGRAL PART OF OUR COMPREHENSIVE CAREMODEL, OUR PHARMACY PROVIDES BLOOD CLOTTING FACTOR PRODUCTS TOPATIENTS AND HOSPITAL PROVIDERS THROUGHOUT THE STATE OF WASHINGTONAND PARTS OF ALASKA, MONTANA, AND IDAHO. PHARMACY SERVICES AT THEWASHINGTON CENTER FOR BLEEDING DISORDERS (WACBD) HAS TWO PRIMARYCOMPONENTS, A LICENSED HEMOPHILIA SPECIALTY PHARMACY, AND A LICENSEDPHARMACEUTICAL WHOLESALER. THE HEMOPHILIA SPECIALTY PHARMACYSUPPORTS CLINICAL OPERATIONS FOR MORE THAN 550 ADULT PATIENTS WHORECEIVE CARE AT OUR MAIN FACILITY IN SEATTLE, WA AND AT OUTREACH CLINICSTHROUGHOUT THE STATE OF WASHINGTON. THE PHARMACY ALSO PROVIDESSUPPORT TO THE MORE THAN 450 CHILDREN WITH BLEEDING DISORDERS WHORECEIVE CARE AT OUR AFFILIATED CHILDREN'S CENTERS LOCATED IN TACOMA,SEATTLE, AND SPOKANE, WASHINGTON. PATIENT SERVICES ARE PROVIDEDPRIMARILY THROUGH THE FILLING OF MAIL ORDER PRESCRITIONS AND PATIENTCOUNSELING ON FACTOR AND NON-FACTOR PRESCRIPTION MEDICATIONS FORTREATMENT OF VARIETY OF BLEEDING DISORDERS. THE WHOLESALE OPERATIONSPROVIDE 24 HOUR A DAY/7 DAY A WEEK SUPPORT TO WACBD CLINICALCONSULTANTS AND OVER 70 HOSPITALS IN WASHINGTON STATE, WHO REQUIREBLOOD FACTOR REPLACEMENT PRODUCTS AND SPECIALTY PHARMACEUTICALSFOR TREATMENT OF PATIENTS WITH BLEEDING DISORDERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $87,876
Program Service Revenue $110,795,343
Investment Income $1,769,155
Other Revenue $22,983
TOTAL REVENUE $112,675,357

Expense Breakdown

Grants Paid $0
Salaries & Benefits $6,965,567
Fundraising Expenses $0
Program Expenses $99,185,361
Other Expenses $94,728,767
TOTAL EXPENSES $101,694,334

Year-over-Year Comparison

2024 2023 Change
Revenue $112,675,357 $122,490,634 -0.1%
Expenses $101,694,334 $108,898,367 -0.1%
Net Income $10,981,023 $13,592,267 -0.2%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
8
Independent Members
6
Employees
55
Volunteers
6

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
5
$614,414
Total Directors
8
$576,344
Key Employees
1
$206,053
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
REBECCA KRUSE-JARRES MD EXECUTIVE/MEDICAL DIRECTOR 40.00
Officer Director
$297,961 $70,987 $368,948
NEIL JOSEPHSON MD PRESIDENT 1.00
Officer Director
$0 $0 $0
KRISHNA JAFA VICE PRESIDENT 1.00
Officer Director
$0 $0 $0
KRISTIAN PRILL HAMILTON BOARD MEMBER 1.00
Director
$0 $0 $0
ROSHNI KULKARNI BOARD MEMBER 1.00
Director
$0 $0 $0
LORI JACOBSEN-TEWS BOARD MEMBER 1.00
Director
$0 $0 $0
SETHU MEIYAPPAN BOARD MEMBER 1.00
Director
$0 $0 $0
KIM SNYDER CFO/COO (THRU 11/24)/BOARD TREASURER 40.00
Officer Director
$183,716 $23,680 $207,396
EVA SZYSZKA CFO/COO 40.00
Officer
$36,525 $1,545 $38,070
HSIN KAI A CHEN PHARMACY DIRECTOR 40.00
Key Emp
$174,064 $31,989 $206,053
JENNIFER LAMHARZI CLINICAL NURSE MANAGER 40.00
Highest
$150,207 $32,465 $182,672
HEEBEEN KIM CLINICAL PHARMACIST 40.00
Highest
$155,485 $20,312 $175,797
ANNE JEZZAMINE CHOI NURSE PRACTITIONER 40.00
Highest
$141,912 $27,962 $169,874
AMY HARRIS CONTROLLER 40.00
Highest
$145,335 $15,632 $160,967
KHOA LE CLINICAL PHARMACIST 40.00
Highest
$141,860 $11,634 $153,494
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $112,675,357 $101,694,334 $87,751,207 $10,981,023
2024 No data No data No data No data
2023 $114,481,287 $104,365,786 $74,267,913 $10,115,501
2022 $53,405,497 $49,511,083 $62,927,219 $3,894,414
2021 $104,303,330 $95,835,264 $62,548,021 $8,468,066
2020 $23,307,124 $5,320,012 $22,969,975 $17,987,112
Explore More Nonprofits
Top 100 Nonprofits in Washington Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare WASHINGTON INSTITUTE FOR COAGULATION with other nonprofits in Washington and across the country.